1 g of the ointment contains 1 mg mometasone furoate (Mometasoni furoas).
Excipient of known effect: propylene glycol monopalmitate stearate
Mometaxon is indicated in the treatment of all skin inflammations and itching, responding to topical corticosteroids, such as psoriasis, atopic dermatitis and contact dermatitis, due to irritation or allergy.
Hypersensitivity to the active substance or any of the excipients.
Do not use in.
acne;
acne rosacea;
atrophic epidermis;
inflammatory conditions around lips;
bacterial infections (e.g. impetigo, abscesses dermatitis), viral infections (e.g. herpes simplex, shingles and varicella, warts, genital warts, molluscum contagiosum), fungal and parasitic skin infections (e.g. caused by dermatophytes or yeasts);
post-immunisation pyrexia;
cutaneous tuberculosis;
syphilis sores;
anal and genital itching;
diaper rash;
damaged and ulcerated skin.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
1 g of the ointment contains 1 mg mometasone furoate (Mometasoni furoas).
Excipient of known effect: propylene glycol monopalmitate stearate
Mometaxon is indicated in the treatment of all skin inflammations and itching, responding to topical corticosteroids, such as psoriasis, atopic dermatitis and contact dermatitis, due to irritation or allergy.
Hypersensitivity to the active substance or any of the excipients.
Do not use in.
acne;
acne rosacea;
atrophic epidermis;
inflammatory conditions around lips;
bacterial infections (e.g. impetigo, abscesses dermatitis), viral infections (e.g. herpes simplex, shingles and varicella, warts, genital warts, molluscum contagiosum), fungal and parasitic skin infections (e.g. caused by dermatophytes or yeasts);
post-immunisation pyrexia;
cutaneous tuberculosis;
syphilis sores;
anal and genital itching;
diaper rash;
damaged and ulcerated skin.
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
